Healthequity Inc

Healthequity Inc(HQY)股票分析

$92.030

-0.479 (-0.52%)收盘时

Loading chart…
最高
93.835
开盘
93.230
成交量加权均价
92.50
成交量
550.70K
市值
7.33B
最低
91.625
成交额
50.94M
企业价值/息税折旧摊销前利润(TTM)
13.78

HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.

AI 分析 of Healthequity Inc (HQY)

买入

HealthEquity Inc is a good buy right now due to its current price of $92.61, which is significantly below the average analyst price target of $115 to $142, indicating potential upside. Additionally, the company's forward P/E ratio is 19.72, suggesting it is reasonably valued for future growth. However, a key risk is the recent insider selling activity, which has increased by 213.73% over the last quarter, indicating potential concerns from insiders about future performance.

分析师评级(10)

上行空间 +27.23%
买入
9 买入
1 持有
0 卖出
当前: 92.03
最低
89.00
平均
117.09
最高
129.00

Barclays

2026-09-18

目标价

$115

Equal Weight

Deutsche Bank

2026-08-31

目标价

$142

买入

BTIG

2026-07-24

目标价

$115

买入

Citizens

2026-06-01

目标价

$111

跑赢大盘

RBC Capital

2026-05-29

目标价

$108

跑赢大盘

估值指标

Healthequity Inc(HQY)当前预期市盈率为 19.72,5 年平均预期市盈率为 29.45。

预期市盈率

低估
5 年均值 P/E
29.45
当前P/E
19.72
高估
38.18
低估
20.71

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
17.30
当前EV/EBITDA
13.78
高估
20.13
低估
14.48

预期市销率

低估
5 年均值 P/S
5.70
当前P/S
4.87
高估
6.43
低估
4.97

Alphio AI 对 HQY 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%HQY

$117.84

情景价格

基

基准

基准 · 50%HQY

$104.80

情景价格

悲

悲观

悲观 · 25%HQY

$75.96

情景价格

持有 HQY 的大户

W

Wealthspire Advisors LLC

+ 持有HQY

+5.91%

3个月收益率

G

Greenhouse Funds LLLP

+ 持有HQY

-0.40%

3个月收益率

W

Wasatch Advisors LP

+ 持有HQY

-0.86%

3个月收益率

N

Nationwide Fund Advisors

+ 持有HQY

-1.49%

3个月收益率

N

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.

+ 持有HQY

-1.66%

3个月收益率

事件时间线

2026-09-30 (ET)

09:30:00

HealthEquity Appoints Moody's CFO to Board

2026-08-27 (ET)

16:30:00

Nvidia's Quarterly Report Drives Tech Stocks Higher

12:30:00

Nasdaq Rises 350.95 Points on Nvidia Earnings

12:30:00

HealthEquity Shares Drop 12.6% to $91.31

10:30:00

HealthEquity Shares Drop 14.1% to $89.74

资讯

HQY 常见问题 —— 由 Alphio AI 解答

HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking. It operates in the Technology sector (SERVICES-BUSINESS SERVICES, NEC industry).

HealthEquity Inc is a good buy right now due to its current price of $92.61, which is significantly below the average analyst price target of $115 to $142, indicating potential upside. Additionally, the company's forward P/E ratio is 19.72, suggesting it is reasonably valued for future growth. However, a key risk is the recent insider selling activity, which has increased by 213.73% over the last quarter, indicating potential concerns from insiders about future performance.

10 analysts cover HQY: 9 rate it Buy, 1 Hold and 0 Sell. The average price target is 117.09.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易